Response to Anti-PD1/L1 Antibodies in Advanced Urothelial Cancer in the 'Real-Life' Setting.

Pharmaceuticals (Basel) · 2022 · PMC9504505 · PMID 36145376

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

Our analysis may also suggest that a higher neutrophil count is associated with a worse response to ICIs, although this association is only borderline significant.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.